“…the metaphor of “a troll lurking under the technology bridge” aptly describes a recent flare-up in the business of getting discoveries across that bridge into the marketplace.”
Also read "Coalition Patent Letter"
Signed by a diverse group of university licensees and others concerned with the direction of patent legislation.
Check out these exciting new videos that showcase a commercialized invention and feature a person who benefited from that technology! They’re the first videos released from AUTM’s Put A Face On It video award program.
The AUTM TransACT Database is a powerful comprehensive database of transactional terms and conditions.
Universities, hospitals, and research centers conduct a lot of research that generates groundbreaking inventions, that save lives and improve the way we live, work, and play on a daily basis. Learn more about how technology transfer benefits you.
Check out AUTM’s newest tool for getting the word out about technology transfer and its positive impact on society. Search the database by keywords and create customizable PDF reports of your results to leave behind or share electronically with meeting attendees, constituents and stakeholders. Plus, AUTM members can now add stories to the database and opt to have them reviewed to be become featured stories on the Better World Project home page.
AUTM members get instant access to online networking and helpful resources and deep discounts on AUTM events and surveys.
Get involved by supporting a committee that suits your interests and availability.
H8 Sharing Data and Assets Across Industry and Academia to Drive the Science Base and Innovation
|Track:||Industry - Academic Relations|
|Target Audience:||All Audiences|
|Moderator:||Malcolm Skingle, Ph.D., GlaxoSmithKline|
|Speakers:||Rowan Douglas, Willis Research Network|
|Helene Rutledge , GlaxoSmithKline|
|Bin Yan, Ph.D., LL.B. , University of Miami W.H Coulter Center|
Increasingly, technology-driven companies are looking to de-risk research and development projects by sharing data and proprietary assets with selected academics in order to expand parts of the science base and to increase their internal knowledge. Many of these projects are co-funded by funding agencies on the assumption that the data generated is deposited into the public domain for all to access. This has driven an interesting dynamic where the corporate company has wanted increased levels of openness and some universities wish to adopt a more secretive approach. Several companies driven by global technology have developed innovative business models with certain universities in recent years in order to increase R&D productivity. These models will be described in detail in order to share what many in industries now consider to be best practice. Recent novel examples from different industrial sectors will be described, including business models from GlaxoSmithKline, Proctor and Gamble, and Willis Ltd, a company specializing in risk adjustment.